1. Home
  2. NVCR vs WERN Comparison

NVCR vs WERN Comparison

Compare NVCR & WERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • WERN
  • Stock Information
  • Founded
  • NVCR 2000
  • WERN 1956
  • Country
  • NVCR Switzerland
  • WERN United States
  • Employees
  • NVCR N/A
  • WERN N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • WERN Trucking Freight/Courier Services
  • Sector
  • NVCR Health Care
  • WERN Industrials
  • Exchange
  • NVCR Nasdaq
  • WERN Nasdaq
  • Market Cap
  • NVCR 1.9B
  • WERN 1.8B
  • IPO Year
  • NVCR 2015
  • WERN N/A
  • Fundamental
  • Price
  • NVCR $19.11
  • WERN $25.95
  • Analyst Decision
  • NVCR Buy
  • WERN Hold
  • Analyst Count
  • NVCR 6
  • WERN 12
  • Target Price
  • NVCR $32.83
  • WERN $30.33
  • AVG Volume (30 Days)
  • NVCR 941.3K
  • WERN 976.9K
  • Earning Date
  • NVCR 07-24-2025
  • WERN 04-29-2025
  • Dividend Yield
  • NVCR N/A
  • WERN 2.16%
  • EPS Growth
  • NVCR N/A
  • WERN N/A
  • EPS
  • NVCR N/A
  • WERN 0.29
  • Revenue
  • NVCR $621,711,000.00
  • WERN $2,973,292,000.00
  • Revenue This Year
  • NVCR $5.56
  • WERN $0.52
  • Revenue Next Year
  • NVCR $9.15
  • WERN $6.30
  • P/E Ratio
  • NVCR N/A
  • WERN $90.35
  • Revenue Growth
  • NVCR 18.27
  • WERN N/A
  • 52 Week Low
  • NVCR $14.17
  • WERN $23.02
  • 52 Week High
  • NVCR $34.13
  • WERN $42.48
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 58.46
  • WERN 41.63
  • Support Level
  • NVCR $18.66
  • WERN $25.86
  • Resistance Level
  • NVCR $20.06
  • WERN $26.68
  • Average True Range (ATR)
  • NVCR 0.86
  • WERN 0.60
  • MACD
  • NVCR 0.19
  • WERN -0.03
  • Stochastic Oscillator
  • NVCR 71.98
  • WERN 12.38

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About WERN Werner Enterprises Inc.

Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.

Share on Social Networks: